Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:584 (6 March), doi:10.1136/bmj.328.7439.584-a
| The first 150 words of the full text of this article appear below. |
EDITORWe agree with Black that improved bed management is not expensive and with Badrinath that other evidence supports our argument that the NHS can learn from Kaiser. Like Evans, we were sceptical of the claims made by Feachem et al in their original paper,1 but as the evidence has changed we have been willing to change our minds.
Ebrahim et al claim that incidence figures for stroke are not available. They seem to have overlooked evidence that shows that the incidence is only marginally lower in the United States than in England (362 per 100 000 compared with 379 per 100 000).2 As admission rates for stroke are also marginally lower in Kaiser than in the NHS, it is difficult to sustain their argument that Kaiser has much higher rates of readmission. In view of the lower mortality in the United States cited by Ebrahim et al it
Chris Ham, director
Strategy Unit, Department of Health, London SW1A 2NS chris.ham@doh.gsi.gov.uk
Nick York, senior economic adviser, Rob Shaw, economic adviser
Economics and Operational Research Division, Department of Health, Leeds LS2 7UE
Steve Sutch, senior consultant
NHS Information Authority, Winchester SO22 5DH
Read all Rapid Responses